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A mathematical model of GLUT1
modulation in rods and RPE
and its differential impact in cell
metabolism
Andrea Aparicio1*, Erika T. Camacho1, Nancy J. Philp2 & Stephen A. Wirkus1
We present a mathematical model of key glucose metabolic pathways in two cells of the human
retina: the rods and the retinal pigmented epithelium (RPE). Computational simulations of glucose
transporter 1 (GLUT1) inhibition in the model accurately reproduce experimental data from
conditional knockout mice and reveal that modification of GLUT1 expression levels of both cells
differentially impacts their metabolism. We hypothesize that, under glucose scarcity, the RPE’s energy
producing pathways are altered in order to preserve its functionality, impacting the photoreceptors’
outer segment renewal. On the other hand, when glucose is limited in the rods, aerobic glycolysis is
preserved, which maintains the lactate contribution to the RPE.
Abbreviations
RPE	Retinal pigmented epithelium
HIV	Human immunodeficiency virus
TCA	Tricarboxylic acid cycle
DHAP	Dihydroxyacetone phosphate
GDS	GLUT1 deficiency syndrome
SLC2A1	Solute carrier family 2 member 1
MCT1	Monocarboxylate transporter 1
PPP	Penthose phosphate pathway
LDHB	Lactate dehydrogenase B
ROS	Reactive oxidative species
OXPHOS	Oxidative phosphorylation
PEP	Phosphoenol pyruvate
GLUT1	Glucose transporter 1
ATP	Adenosine triphosphate
HK2	Hexokinase-2
RdCVF	Rod-derived cone viability factor
SLC1A1	Solute carrier family 1 member 1
OS	Outer segments
MCT3	Monocarboxylate transporter 3
KP	Kennedy pathway
NADPH	Nicotinamide adenine dinucleotide phosphate
G3P	Glyceraldehyde 3-phosphate
HKII	Hexokinase 2
Systems biology is transforming current approaches to biological research and therapeutic treatments. Mathematical models that accurately describe biological processes have become a standard tool to investigate the
interconnectedness of complex regulatory processes and how disruptions of these processes may contribute to
the development of disease1–3. Successful applications range from cancer and human immunodeficiency virus
(HIV) research, energy metabolism analysis, and the design of drugs and assistive devices for their delivery,
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to the study of specific disease progression in the r etina4–13. A mathematical model that accurately reproduces
experimental data allows one to verify new hypotheses, analyze perturbations, and explore potential hypotheses
and treatment options via computational simulations, yielding results quickly and at an extremely low cost.
Numerical simulations provide a computationally informed perspective of the functioning of the system, key to
the design of new experiments, shifting the paradigm of biological sciences.
The retina is the light-sensitive tissue of vertebrates’ eyes and serves as the sensor with which vision is enabled.
It consists of various layers of interconnected cells. Here we provide an analysis of the interconnected mechanisms
and metabolic processes of two cells located in the outer human retina: the retinal pigmented epithelium (RPE)
and the rod photoreceptors. We focus on the role that glucose transporter 1 (GLUT1) plays in these functions.
The RPE is a structurally and functionally polarized epithelia14 that serves as a selective barrier in the retina,
regulating the vectorial transport of nutrients into the retina, phagocytosis of shed outersegments, and visual
pigment regeneration15. Glucose is the primary metabolic substrate of the neural retina and the RPE facilitates
the transepithelial transport of glucose from the choriocapillaris to the outer retina via GLUT116. The RPE’s apical
surface faces the interphotoreceptor matrix, through which metabolites are exchanged with photoreceptor and
Muller glial cells in the outer neural retina17.
Photoreceptors convert light into electric impulses that are transmitted to the brain for image interpretation.
They are sensory epithelium with outer segment connected to the inner segment via a connecting cilium. The
outer segments are comprised of stacks of membrane discs that have a high concentration of the light sensitive
protein opsin bound to 11-cis retinal. There are two main kinds of photoreceptors: rods and cones. The rods
are extremely sensitive to light and are responsible for night vision. Cones are relatively insensitive to light and
are responsible for high acuity central vision and color v ision18. Photoreceptors are among the most energydemanding cells in the body19 and they utilize glucose in the pentose phosphate shunt to produce intermediates
required for outer segment renewal, and for adenosine triphosphate (ATP) production. The latter, though significant, is known to mainly maintain the dark current in photoreceptors. If the ATP level is too low, an energetic
crisis that initiates cell death can occur but, under normal circumstances, ATP can be assumed constant. In these
retina cells the metabolism of glucose through aerobic glycolysis is favored over oxidative phosphorylation and
the tricarboxylic acid cycle (TCA); approximately 80–90% of glucose is converted to lactate20 in adult photoreceptors, even when oxygen is present. This phenomenon is well identified in cancer and other proliferating
cells and is part of many photoreceptor-related investigations16,20–24. The produced lactate is then transported
to the RPE and into the choroidal circulation16. When glucose is scarce, the expression of the glycolysis enzyme
hexokinase-2 (HK2) i ncreases25. HK2 helps photoreceptors retain glucose for glycolysis and consequently divert
the subsequent metabolic product dihydroxyacetone phosphate (DHAP) to the Kennedy pathway, responsible of
forming phospholipids and helping maintain the regeneration of photoreceptor outer s egments25–28.
The RPE and the photoreceptors are metabolically coupled and act as a functional unit. The RPE oxidizes fatty
acids from ingested outer segments and lactate produced through aerobic glycolysis in the outer retina to support
its metabolic demands. This allows glucose from the choroidal circulation to be spared for the outer retina28. In
healthy conditions, the RPE consumes more lactate than the photoreceptors, and the photoreceptors consume
more glucose than the RPE29. The rods photoreceptors help the cones photoreceptors accelerate the uptake of
glucose via the rod-derived cone viability factor (RdCVF). This symbiotic relationship maintains metabolic
homeostasis, and genetic and environmental perturbation of either the RPE or photoreceptor cells can cause
perturbations in nutrient flux leading to atrophy of the RPE and degeneration of photoreceptors. For example, if
for any reason glucose uptake in insufficient in the retina, the lactate production by the photoreceptors for RPE
metabolism decreases. In this case, the RPE retains the available glucose as a substrate for its own metabolism
rather than transporting it to the p
 hotoreceptors16,30. Glucose can be metabolized by the RPE if lactate production
by the outer retina is reduced or lactate transporters are inhibited. On the other hand, under glucose scarcity, the
metabolites produced from the outer segments’ fatty acids can be used to fuel the photoreceptors instead of the
RPE16,30–32; this is known to happen in patients with retinitis pigmentosa33. However, this seeming competition
might in fact be the ecosystem’s defense mechanism to preserve its most critical functions when under stress.
GLUT1 is found on both the apical and basolateral membranes of the R
 PE34,35 to facilitate transepithelial
transport of glucose from choroidal vessels to the outer neural r etina28. RdCVF binds to basigin-1 (Bsg1) and and
stabilizes GLUT1 in the plasma membrane of photoreceptors to enhance glucose uptake. The GLUT1 deficiency
syndrome (GDS) is an autosomal dominat disease caused by mutations in the solute carrier family 1 member
1 (SLC1A1) gene and is associated with many disorders including epilepsy, body movement disorders and
speech impairments36,37. In Pascual et al.38, several non eye-specific GLUT1 deficiency disorders are reviewed.
However, GDS has not been found to impact vision in humans or in mice that are heterozygous for the solute
carrier family 2 member 1 (SLC2A1) gene. In fact, results of several experimental works suggest that GLUT1
inhibition can suppress diabetic retinopathy by decreasing retinal glucose and, thus, GLUT1 is often targeted by
diabetic retinopathy drugs39. Nevertheless, as demonstrated in Henry et al.39 by means of a human case study,
GLUT1 inhibition can be detrimental for retinal activity and vision because of its contribution to photoreceptor
degeneration. Indeed, experiments in mice have shown that if GLUT1 expression falls below a certain critical
threshold then photoreceptor outer segments (OS) renewal and photoreceptor cell survival are negatively affected;
the impact was found to be greater for rods (reflected by a 50% reduction in rod photoreceptor OS length and
a 50% rod cell death) than for cones (reflected by a 10% reduction in cone photoreceptor OS length and a 17%
reduction in cone cell number28). Still, the cones are also ultimately affected by GLUT1 deprivation due to their
dependence on RdCVF, synthesized by r ods22. In Retinitis Pigmentosa, photoreceptors upregulate GLUT1 and
HK240,41, which indicates that these cells are attempting to metabolize more glucose through aerobic glycolysis.
Investigating the mechanisms that promote or hinder rod survival is thus of great importance to understand
the progression of this and other diseases related to both types of photoreceptors’ death that lead to irreparable
blindness, such as age-related macular degeneration. Insights in this area will pave the way towards helping design
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therapeutic treatments that might stop, reverse and even prevent such conditions. On the other hand, it has
been observed that the deletion of GLUT1 does not affect the RPE’s differentiation, functions, or the polarity of
monocarboxylate transporter 1 (MCT1) and 3 (MCT3) -responsible of lactate transport- but that it significantly
impacts the capacity of the RPE to transport glucose into the outer retina28.
In this work we study the physiological connections between the RPE and the rods in terms of metabolic
pathways, metabolite exchange, and the regulating mechanisms that govern them. We propose a mathematical
model of the RPE-rod unit focusing on glucose and lactate transport where a feedback loop between the RPE and
the rods is in place, and the delicate balance between the different metabolic pathways, necessary for cell homeostasis, is kept by a set of regulating mechanisms. We define feedback interconnections through which glucose and
lactate are interchanged, and characterize their regulation by the abundance or lack of other metabolites, enzymes
or proteins. In order to validate the accuracy of our model, we run computational simulations and compare our
numerical results of metabolite concentrations in a healthy cell to those reported in Kanow et al.42. The immediate
objective of the described model is to analyze the impact of GLUT1 modulation in the different metabolic steps
of RPE and rods in order to draw conclusions on their robustness and ability to adjust or adapt to disturbances.
Through computational research we identify dangerous conditions before cell degeneration occurs, as well as
potential mechanisms that might contribute to the development of diseased states or cell death. To this end, we
run simulations of our model with similar conditions of GLUT1 concentration to the ones reported in Swarup
et al.28 and make sure that our model accurately reproduces the experimental results. We then test conditions
beyond the experimentally examined ones, obtaining a large set of numerical data.
This is the first model of its type to consider the interactions between the RPE and the rods. It is also the first
to allow modifications to its parameters to represent different states of health or disease. We have aimed here to
include the most significant key components in order to optimize the model construction and its corresponding
mathematical calculations. The ultimate goal of this model is not to replace wet experiments, but to inform and
guide them. In turn, the data produced by these future experiments can be then used to better tune the model,
thus completing a cycle that, we believe, can advance the field. We expect this work to be the starting point in
building a complete but practical computational model of the lactate-mediated metabolic exchange in the retina.
The remainder of this manuscript is organized as follows: “Mathematical model” section describes the proposed model that defines the dynamics of the rods and the RPE. First, a high-level block diagram that sketches
the structure of the considered connections and internal pathways of the two cells is presented. Then, the key
metabolites that integrate the metabolic pathways are organized in the form of a network, which also includes
the regulating functions. Last, a set of differential equations that constitute the mathematical model is presented.
“Healthy conditions” section reveals the numerical results of the dynamical system (represented by nonlinear
equations), and explains how our model is validated using experimental data. “[GLUT1] modulation” section
presents the motivation and predictive capabilities of this work by illustrating the effect that modulating GLUT1
has in the metabolite concentrations of the rods and the RPE. Finally, “Conclusions” section summarizes the
results, presents some perspectives and proposes directions for future work.

Results

Mathematical model.

Metabolic pathways and regulating mechanisms. To explore the key metabolic
mechanisms in the RPE and rods we consider these systems in a vacuum with a minimal number of elements. In
order to optimize the feasibility of the mathematical analysis we have opted to limit the amount of components
to only those of the most significant contributions as per the available information. Figure 1 shows a diagram
of the model that we propose. This diagram describes the metabolic flow, pathways, and feedback mechanism
between the RPE and the rods considered in our work, isolating key elements of lactate and glucose exchange.
The four pathways that we consider in this work are: glycolysis, aerobic glycolysis, penthose phosphate pathway
(PPP) and Kennedy pathway (KP). The inclusion of these particular pathways will allow us to obtain quantitative data of the influence of the regulating mechanisms on each other and on the overall health of the cells. The
modular structure of the model facilitates the further addition of other components that are not included in this
first approach in its kind.

RPE. Glucose is transported from the choroid into the RPE by GLUT1, on its basal surface. On its apical surface, glucose is transported into the outer retina also by GLUT1. It has been found that the RPE directs most
of the available glucose to the outer retina where it is metabolized through aerobic glycolysis, producing large
amounts of lactate29. The MCT1 in the apical membrane facilitates the uptake of lactate from the subretinal space
where it is converted into pyruvate by lactate dehydrogenase B (LDHB) to be oxidized and in the TCA cycle42
(see Fig. 1). Excess lactate is transported out of the RPE to the choroidal venules via MCT3 found in the basolateral membrane of the cells. When the RPE cannot get sufficient lactate for metabolism, it metabolizes glucose
coming from the choroid (for use in glycolysis), rather than sparing it for the photoreceptors. This eventually
diminishes the glucose in the rods. This follows the findings in Léveillard16 which establish that the direction of
the glucose flux depends on the difference in lactate concentration between the interphotoreceptor matrix and
the cytoplasm of the RPE cell. In the same work it is stated that a deficit in lactate clearance at the basal side of the
RPE will trigger a decrease in transport on the apical side, resulting in an increase of lactate concentration in the
inter-photoreceptor matrix (the space between photoreceptors) and reversing the polarity of lactate transport. It
is also known that the presence of enough lactate to fulfill the RPE’s pyruvate needs blocks glycolysis in the RPE42
which, again, suggests that if lactate is insufficient in the retina, the RPE’s glycolysis process is unblocked and
therefore transepithelial transport of glucose from the choroidal circulation to the photoreceptors is decreased.
This indicates the presence of a lactate-dependent glucose regulation mechanism in the RPE, controlling the
amount of glucose directed to the photoreceptors versus the amount uptaken by the RPE. In our model we only
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Figure 1.  Diagram of key metabolic pathways (glycolysis, aerobic glycolysis, penthose phosphate pathway
(PPP), and Kennedy pathway (KP)), transporters (GLUT1, MCT1), enzymes (lactate dehydrogenase B
(LDHB)), and feedback metabolite flow between the RPE and the rods considered in our model. The metabolic
pathway blocks represent several enzymatic reactions, and each reaction uses a specific metabolite as substrate
to produce another metabolite. The RPE transports glucose from the choroid into the photoreceptors and keeps
only a small portion to be converted into pyruvate through glycolysis. The transport is enabled by GLUT1.
Once in the photoreceptors, glucose enters the glycolysis pathway from which intermediate metabolites are
directed to the PPP and KP. Pyruvate, the end product of glycolysis, is reduced into lactate by aerobic glycolysis
in the rods. Lactate is cleared from the rods, and transported to the interphotoreceptor matrix by MCT1, which
also transports it into the RPE. Inside the RPE, lactate is converted to pyruvate by LDHB to be oxidized and
processed by the tricarboxylic acid cycle, also known as the Krebs cycle.

consider the RPE and the rods and focus on the interplay between glucose transport to the rods and lactate from
these photoreceptors fueling the RPE metabolic process. Since we do not explicitly model lactate in the RPE we
use its pyruvate concentration as a proxy that, together with the external lactate from the rods, modulates the
changes in glucose transport to the rods in response reduction in the RPE’s metabolic fuel.
Rods. Four metabolic pathways will be considered in the rods’ part of our mathematical model (see Fig. 1):
Glycolysis, pentose phosphate pathway (PPP), Kennedy pathway (KP) and Aerobic Glycolysis. Glucose entry is
enabled by GLUT1 and is incorporated to the glycolysis pathway. Intermediate products of glycolysis are used
to feed the PPP and the KP. The PPP produces nicotinamide adenine dinucleotide phosphate (NADPH) which
reduces oxidized glutathione to reduced glutathione, that then neutralizes the toxic effects of reactive oxidative
species (ROS)23, helping the cells cope with oxidative stress. The KP has two branches: DP-choline and CDPethanolamine. These are the predominant pathways responsible for the synthesis of the most abundant phospholipids, phosphatidylcholine and phosphatidylethanolamine in mammalian membranes43. It regulates the balance
between phospholipids and neutral lipids44, and produces glyceraldehyde 3-phosphate (G3P), (the precursor of
the glycerol backbone of phospholipids), to promote the OS renewal process. In the KP, fatty acids are combined
with glycerol (produced from the G3P) to form the phospholipids which is necessary for membrane synthesis16.
Note that this part of our model represents a whole rod, unlike previous models that describe the functions of
photoreceptors outer segments only. It has been established that the central metabolic role of photoreceptors
in retinal energy metabolism is to convert glucose to lactate, and that lactate is distributed to the RPE to be
used as fuel42. This is done through aerobic glycolysis18. It has been demonstrated experimentally that aerobic
glycolysis is also necessary for replenishing 10% of the OS that are shed each day by the photoreceptors45. The
large amounts of lactate produced is cleared from the rods by MCT1, which also enables the RPE to absorb this
metabolite for its conversion into pyruvate, to be utilized in its TCA for energy p
 roduction46. If lactate cannot
be cleared from the photoreceptors and transported into the extracellular space, the concentration of internal
lactate increases, provoking a shift in the gradient that leads to the conversion of lactate back into pyruvate using
LDHB. This pyruvate then goes to the mitochondria to facilitate in ATP production. Pyruvate leakage from the
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Figure 2.  Network structure of the metabolite interactions in the rods and the RPE considered in our proposed
mathematical model. Every node in the network represents the abundance of a specific metabolite. Blue
nodes correspond to the metabolites in the RPE, denoted by the subscript E, and purple nodes correspond to
the metabolites in the rods, denoted by the subscript r. The orange node represents the extracellular glucose.
The enzymatic reactions by which metabolites are used and produced are represented by links: a link x → y
indicates that the concentration of metabolite y directly depends on the concentration of metabolite x, in
a substrate → product manner. A link x−− ↓ indicates that the corresponding reaction is regulated by a
mechanism dependent of metabolite x. The abbreviations used for the metabolites are: [gz](t) for glucose
inside the cell, [G6Pz](t) for glucose 6-phosphate, [F16BPz](t) for fructose 1,6-bisphosphate, [NADPHz](t) for
nicotinamide adenine dinucleotide phosphate, [PYRz](t) for pyruvate, [LACTz](t) for lactate, and [G3Pz](t) for
glyceraldehyde 3-phosphate.

mitochondrial respiratory chain results in the accumulation of reactive oxidative species which contributes to
photoreceptor degeneration47. Under healthy conditions, glycolysis in photoreceptors favors lactate formation
rather than lactate utilization. Photoreceptors also divert some of the pyruvate that they produce to oxidative
phosphorylation (OXPHOS) for the TCA cycle instead of using it for lactate production, but the amount is generally estimated to be between 5 and 20% only for experimental animal m
 odels48,49 and thus it is not considered
in this model. The glucose uptake, lactate clearance, and intermediate metabolite redirection operations depend
on a delicately balanced homeostasis, which suggests the existence of various regulating mechanisms to ensure
it.
Network. Each pathway in Fig. 1 encompasses several metabolic steps that transform glucose into various
intermediate products, and that are governed by specific enzymatic reactions. Figure 2 portrays the metabolic
steps considered in our mathematical model, as well as the interaction between metabolites and the mechanisms
that regulate such interactions, in the form of a network. Every node represents the abundance of a specific
metabolite: blue nodes correspond to the metabolites in the RPE, denoted by the subscript E, and purple nodes
correspond to the metabolites in the rods, denoted by the subscript r. The orange node represents the extracellular glucose. The enzymatic reactions by which metabolites are used and produced are represented by links: a link
x → y means that the concentration of metabolite y directly depends on the concentration of metabolite x, in a
substrate → product manner. A link x−− ↓ means that the corresponding reaction is regulated by a mechanism
dependent on metabolite x. The regulating functions of our system, denoted E , E , r , and r , are either of
the activation or inhibition type, and they correspond to the regulating mechanisms previously described and
in Fig. 2. These functions and their activator or inhibitory properties will be defined in “Mathematical model
derivation” section. Every metabolite included in our model plays a role in either reflecting the health of the cell,
or dictating the behavior of the regulating mechanisms. Other metabolic steps and pathways that exist in the
rods and the RPE have been excluded from this mathematical model in order to keep a minimal amount of variables while getting enough significant quantitative information. This network will serve as a basis to define the
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mathematical equations that underlie the RPE-rod ecosystem, which will also be established in “Mathematical
model derivation” section.
Mathematical model derivation. Through the rest of this section we will establish mathematical expressions
that describe the dynamics of the model proposed in Figs. 1 and 2. In this work we use the notation defined
below.
For a cell z, where z = E represents the RPE and z = r represents the rods (Fig. 2), the abundances of its
metabolites at time t are represented by the following variables:

[gz ](t): glucose inside the cell,
[G6Pz ](t): Glucose 6-phosphate,
[F16BPz ](t): Fructose 1,6-bisphosphate,
[NADPHz ](t): Nicotinamide adenine dinucleotide phosphate,
[PYRz ](t): Pyruvate,
[LACTz ](t): Lactate, and
[G3Pz ](t): Glyceraldehyde 3-phosphate.
For simplicity, the argument (t) will be dropped in the rest of this paper. The metabolites pertaining to the RPE’s
metabolic processes will be denoted as z = E , and those pertaining to the rods’ metabolic processes will be
denoted as z = r . The term d[y]
dt represents the rate of change of metabolite [y]. The term νy represents the kinetic
rate functions of metabolite [y] . Vmax[y] is the maximum transport rate of metabolite [y], and Km[y] is the substrate
concentration that gives half the maximum of the transport rate of metabolite [y].
Building from the mathematical model and framework in Camacho et al.50, and adapting similar reactions
and steps, we develop our model. We consider the change in the concentration of substrate with respect to time
to be equal to the reaction rate for that concentration of substrate minus the reaction rate of the concentration
of the product resulting from catabolizing that substrate with an enzyme. For example, the change in the cond[g ]
centration of glucose in the RPE, dtE , is given by its own kinetic rate function νgE , minus the kinetic rates of the
metabolites resulting from catabolizing [gE ], i.e., νG6PE and νgr:

d[gE ]
= νgE − νG6PE − νgr .
dt
Using the above expression and following the same method for every metabolite (node) in Fig. 2, we can readily
establish the set of differential equations that describe the rate of production of every metabolite in our model as:
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d[gE ]
= νgE − νG6PE − νgr
dt

(1)

d[G6PE ]
= νG6PE − νF16BPE
dt

(2)

d[F16BPE ]
= νF16BPE − νPYR E
dt

(3)

d[PYRE ]
= νPYR E + νPYR rE − ψPYR E [PYRE ]
dt

(4)

d[gr ]
= νgr − νG6Pr
dt

(5)

d[G6Pr ]
= νG6Pr − νF16BPr − νNADPHr
dt

(6)

d[NADPHr ]
= νNADPHr − ψNADPHr [NADPH]
dt

(7)

d[F16BPr ]
= νF16BPr − νPYR r − νG3Pr
dt

(8)

d[G3Pr ]
= νG3Pr − ψG3Pr Rp [G3Pr ]
dt

(9)

d[PYRr ]
= νPYR r − νLACTr
dt

(10)

https://doi.org/10.1038/s41598-022-13950-3

6

www.nature.com/scientificreports/

d[LACTr ]
= νLACTr − ψLACTr [MCT1][LACTr ].
dt

(11)

The Eqs. (4), (7), (9), and (11) have additional terms that are not kinetic rate functions and that represent
the amount of the corresponding metabolite consumed by a particular pathway. Specifically, the terms
ψPYR E , ψNADPHr , ψG3Pr , and ψLACTr represent the consumption or clearance by the RPE’s TCA, the rods’ PPP,
the rods’ KP, and the rods’ MCT1-dependent lactate clearance process, respectively, and are approximated by
constants. The metabolites whose dynamics include these consumption or clearance terms correspond to the
end nodes in Fig. 2, i.e., those nodes do not have any outgoing links. The details of the remaining terms of the
equations are discussed below.
The solutions to the differential Eqs. (1)–(11) represent the concentrations of metabolite at any time t. From
Fig. 2 we see that the formation of every product depends on only one substrate, except for the pyruvate in the
RPE, which has two arrows coming into it. This is reflected in the fact that every Eqs. (1)–(11) has only one
positive term, except for (4) that has two. This information will be key to determining every metabolite’s kinetic
rate functions below. The first step in our model is the incorporation (or production) of glucose inside the RPE,
denoted by [gE ], which is the result of the binding of glucose outside the cell [G], which is the substrate, with the
transporter GLUT1, forming a new complex. This new complex then releases glucose inside the cell as a product,
preserving the t ransporter51. The reaction can be written as:

[G] + [GLUT1] ⇋ [G/GLUT1] → [gE ] + [GLUT1].

(12)

We take the activation of glucose as an allosteric reaction, which means that there is a binding time requirement
for the enzyme to catalyze the formation of the product. We model this kind of reaction as a functional response
of Holling’s Type III, in accordance with previous works11,50, where the exponent applied to the variables in the
numerator and denominator qualitatively portrays the reaching time and approximation to saturation of every
reaction. Thus, the kinetic rate function νgE is given by

νgE = E [GLUT1] ([G] − [gE ])

Vmax[gE ] [G]2
2
Km
+ [G]2
[g ]

,

(13)

E

where Vmax[gE ] and Km[gE ] are constant.
In these kind of reactions the enzyme is preserved, so the kinetic rate functions of the products are normally
only a function of its substrate ([G] in this case). Since the transport of glucose follows the gradient of the external and internal glucose, and it is facilitated by GLUT1, the kinetic reaction is regulated by the term [GLUT1]
([G]-[gE]). The parameter [GLUT1] represents the transporter’s relative concentration with respect to a healthy
retina. Its maximal allowed value is [GLUT1] = 1, which means that glucose absorption is facilitated in a normal
manner due to a healthy concentration of the transporter. The minimum allowed value, [GLUT1] = 0, represents
the case of GLUT1 knockout which means an absolute lack of transporter. In this case no glucose can be absorbed
into the RPE. The term ([G] − [gE ]) indicates the direction of the glucose flow. It is important to note that in
our model the abundance of the external choroidal glucose should always be kept larger than the internal RPE
glucose, i.e., [G]>[gE ], so that the flow will be from the outside of the cell towards its inside, in accordance with
the unidirectionallity of the second arrow in (12). Finally, E is a constant scaling factor.
The production of G6P in the RPE uses the glucose incorporated in the RPE as a substrate. The enzyme that
enables this reaction is hexokinase 2 (HKII), and the reaction is written as

[gE ] + [HKII] ⇋ [gE /HKII] → [G6PE ] + [HKII].

(14)

This step marks the initialization of glycolysis in the RPE. In our proposed model it is regulated by the function
E , which depends on the concentration of pyruvate in the RPE (see the link [gE ] → [G6PE ] in Fig. 2). The glycolysis process in the RPE can be blocked or activated depending on whether enough lactate can be absorbed
to fulfill the RPE’s pyruvate requirements or not. We model the RPE’s pyruvate requirement with the constant
[PYRE*], and use the following f unction50 to model the RPE glycolysis regulation:

E =

[PYRE ∗]4
.
[PYRE ∗]4 + [PYRE ]4

(15)

Function (15) can take values between 0 and 1, and its curve with respect to the [PYRE ] concentration is shown in
Fig. 3 (blue line). When the pyruvate concentration in the RPE is abundant with respect to [PYRE*], i.e., [PYRE ]
> [PYRE*], the numerical value of E is low. This means that as long as there is enough [PYRE ], most of the
glucose will be redirected to the rods and very little will be utilized by the RPE for glycolysis. If [PYRE ] becomes
scarce, the value of E increases, favoring glucose uptake in the RPE, activating its glycolysis. We use the power
4 to approximate a step function without introducing the complication that a discontinuous function or higher
powers would add. As a consequence of low levels of [PYRE ], the glucose available for intake by the rods will be
reduced. From the reaction (14), and function (15), we define the kinetic rate function as

νG6PE =

Vmax[G6PE ] [gE ]2
2
Km
+ [gE ]2
[G6P ]

�E .

(16)

E
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4

E ∗]
Figure 3.  The regulating function E = [PYR[PYR
4
4 (blue line), and its complement �E = (1 − �E )
E ∗] +[PYRE ]
(orange line) take values between 0 and 1 depending on the concentration of [PYRE ] with respect to the
constant [PYRE*]. This parameter represents the healthy RPE’s requirement of pyruvate, and determines the
proportion of glucose that the RPE keeps for its own glycolysis pathway, and the proportion that it is diverted
to the rods. For low E (high E ), the RPE’s glucose utilization is blocked (and redirection of glucose to the
photoreceptors is favored). Conversely, high E (low E ) favors the RPE’s retention of glucose, activating its
glycolysis (and blocking the transport of glucose to the rods). Both lines intersect at precisely [PYRE] = [PYRE *]
(red star).

Our model is designed to account for knock-out type experiments where a certain gene is disrupted or eliminated from specimens. The extreme case of a gene’s total deletion might lead to the total absence of a certain
metabolite. Considering the case when the reserve of [PYRE ] is exhausted, i.e. [PYRE]≈ 0, the regulating function (15) reaches its extreme value of E ≈ 1, activating glycolysis in the RPE at its maximum capacity. On the
other hand, if [PYRE ] accumulates in extremely large quantities, the regulating function (15) becomes E ≈ 0,
blocking the RPE’s glycolysis with νG6PE ≈ 0.
In our model we assume that any intermediate steps between the production of the G6P and F16BP in the
RPE always happen once glycolysis has been initiated. For the remaining metabolic steps in the RPE we will skip
writing the enzymatic reactions and we will focus on defining the kinetic rate functions that explicitly appear
in our differential equations. The kinetic rate function that governs the production of F16BP using G6P as a
substrate is given by

νF16BPE =

Vmax[F16BPE ] [G6PE ]2
2
Km
+ [G6PE ]2
[F16BP ]

.

(17)

E

In our model, pyruvate is considered the end product of the RPE’s glycolysis. Any intermediate steps between the
production of F16BP and the release of pyruvate are assumed to always happen and thus we model the pyruvate’s
kinetic rate function using F16BP as a substrate as:

νPYR E =

Vmax[PYRE ] [F16BPE ]2
2
Km
+ [F16BPE ]2
[PYR ]

.

(18)

E

Note that this reaction is different from the one that converts the external lactate that the RPE receives into
pyruvate, for which we use νPYR rE in (4), and that will be defined later.
The incorporation of glucose inside the rods is the result of the binding of the glucose outside the cell with
[GLUT1]. In this case, the glucose outside the cell is represented here by [gE ] (the glucose that passes through
the RPE), and its passage is regulated by the function E , defined below and as illustrated by the link [gE ] → [gr ]
in Fig. 2. The corresponding reaction can then be expressed as

[gE ] + [GLUT1] ⇋ [gE /GLUT1] → [gr ] + [GLUT1].

(19)

The kinetic rate function of the rods’ glucose intake is modeled as

νgr = r [GLUT1] ([gE ] − [gr ]) 

Vmax[gr ] [gE ]2

Km[g ] 2
r
+ [gE ]2
�E

(20)

where, in a similar way as in Eq. (13), we explicitly include the parameter [GLUT1] to represent the transporter’s
relative concentration, and r is a constant scaling factor. In order to accurately represent the direction of glucose
flow from the RPE to the rods, the term ([gE ] − [gr ]) must be kept positive. The regulating function E is between
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0 and 1 and acts to inhibit the catalytic reaction of the glucose activation in the rods when there is not enough
pyruvate in the RPE and is defined as the complement of function E , that is,
(21)

E = 1 − E .

concentration
In other words, when �E < 1, the catalytic reaction in (20) will get inhibited and the substrate



giving half maximal velocity of the reaction catalyzed by the allosteric enzyme, defined as

Km[g ]
r
E

, is increased.

Function (21) can take values between 1 and 0, and depends on the value of [PYRE ] with respect to a constant
[PYRE *] (see Fig. 3). If pyruvate is scarce in the RPE, i.e., [PYRE]<[PYRE*], the numerical value of E is very low,
thus increasing the inhibition of the catalytic reaction in (20) and lowering the rods’ intake of glucose. If there
is sufficient pyruvate to meet the RPE’s requirements, i.e., [PYRE]>[PYRE*], the numerical value of E is high,
thus lessening the inhibition of the reaction in (20) and increasing the rods’ intake of glucose.
The rods initiate their glycolysis process after glucose intake. In our model the rods’ glycolysis consists of the
same three steps as the RPE’s glycolysis: the conversion of glucose into G6P, the conversion of G6P into F16BP
and the conversion of F16BP into pyruvate. Again, we assume that any intermediate steps between these three
always happen. The reactions that govern these steps are assumed to be identical to the corresponding ones in
the RPE’s glycolysis, except for their regulating terms. The kinetic rate function of the rods’ first glycolytic step,
which uses glucose as a substrate to produce G6P, is then modeled by:

νG6Pr =

Vmax[G6Pr ] [gr ]2
.
2
Km
+ [gr ]2
[G6Pr ]

(22)

One major difference between the RPE’s and the rods’ metabolic processes in our model is that while it is assumed
that all the glucose that starts down the glycolytic pathway in the RPE is used to produce pyruvate, in the rods
we also consider the diversion of glycolysis intermediate products to the PPP and the KP (see the rods’ glycolysis
block in Fig. 1).
Following Camacho et al.50, we model the diversion of glucose into these pathways. The regulating function
r can take values between 1 and 0, and determines the proportion of the rods’ G6P that will be directed to PPP,
enabling the production of NADPH. Its complement, r = 1 − r , determines the proportion of the rods’ G6P
that will continue to the next step of glycolysis, which produces F16BP. In Camacho et al.50, [PEP*] is defined to
be the critical amount of phosphoenol pyruvate (PEP) that grants the diversion of glucose into the PPP or down
the glycolysis path. PEP is a metabolite produced in an intermediate step, right before the production of pyruvate,
and is not explicit in our equations; therefore, we use [PYR]r as a proxy for it. Accumulation of PEP in the rods
results in the inhibition of triose phosphate isomerase, which is necessary for the diversion of G6P down the
glycolysis pathway. In this case, the rerouting of G6P into the PPP is activated. This also interrupts diversion of
glucose into KP, the subsequent catalytic reaction of G3P, and the production of phospholipids. The value of the
regulating function r depends on the relation of [PEP*] to [PYRr ] and is defined as

r =

[PYRr ]4
[PEP*]4 + [PYRr ]4

.

(23)

The kinetic function rates of [F16BPr ] and [NADPHr ] are given by

νF16BPr =

Vmax[F16BPr ] [G6Pr ]2
�r ,
2
Km
+ [G6Pr ]2
[F16BPr ]

(24)

Vmax[NADPHr ] [G6Pr ]2
�r ,
2
Km
+ [G6Pr ]2
[NADPHr ]

(25)

and

νNADPHr =

respectively.
The function (23) and its complement r = 1 − r have analogous behavior to the functions E and E in
(15) and (21). If there is not enough PEP to start PPP, i.e., [PYRr ]<[PEP*], the value of r will be low and the
value of r will be high, which will favor glycolysis and inhibit the production of NADPH. In the opposite case,
if PEP accumulation surpasses the critical value, i.e., [PEP*]<[PYRr ], the value of r will be high and the value
of r will be low, which will favor the PPP and inhibit the production of F16BP and the rest of the glycolytic
products. Looking at Fig. 3, if the horizontal axis is now the concentration of [PYRr ], that is a proxy for PEP, the
orange line would represent r and the blue line would represent r . The two lines meet at the red star, which
in this case would represent the optimal PEP concentration, represented by [PYRr ] = [PEP*].
In our model, the last step in the glycolysis pathway of rods produces pyruvate from F16BP. Meanwhile, F16BP
is also the substrate for the production of G3P in the KP. The diversion of F16BP towards the end of glycolysis
and towards the KP is assumed to be regulated at a constant rate, represented by a constant qr ∈ (0, 1), with a
healthy value of qr = 0.1850. When qr < 0.18 glycolysis is favored and, when qr > 0.18, the KP is favored. The
kinetic rate functions of [PYRr ] and [G3Pr ] are given by
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νPYR r =

Vmax[PYRr ] [F16BPr ]2
(1 − qr ),
2
Km
+ [F16BPr ]2
[PYRr ]

(26)

Vmax[G3Pr ] [F16BPr ]2
qr ,
2
Km
+ [F16BPr ]2
[G3Pr ]

(27)

and

νG3Pr =

respectively.
In most cells, if there is oxygen available, pyruvate is metabolized through the very efficient OXPHO (as is
the case in the RPE); however, a distinctive characteristic of rods is that they opt to ferment pyruvate into lactate,
even in the presence of oxygen. This process is known as aerobic glycolysis and is known to be a hallmark of
cancer cells16,20–23. The transformation of the rods’ pyruvate into lactate is the last step of the rods’ metabolism
in our model, and its kinetic rate function is

νLACTr =

Vmax[LACTr ] [PYRr ]2
(1 − ρr ),
2
Km
+ [PYRr ]2
[LACT ]

(28)

r

where ρr is a constant, with 0 ≤ ρr ≤ 1, and represents the proportion of ROS produced by leakage of the mitochondrial respiratory chain. In healthy conditions, very little leakage occurs.
The lactate produced by the rods is cleared towards the interphotoreceptor matrix and transported into the
RPE by MCT1, closing the feedback loop between the two cells (see the green arrows in Fig. 1). We use the variable [LACTEx ] to represent the amount of external lactate that is uptaken by the RPE. Note that this lactate is
considered to exclusively come from the rods (cleared by MCT1) and not any other cell, i.e., lactate contributions
to the RPE from any cell other than the rods are not included in our model. Because this step is not a chemical
reaction, but the clearance of a metabolite from the rods regulated by a transporter protein, the amount of rodsupplied lactate that makes it into the RPE is calculated as an algebraic function of the abundance of MCT1,
represented by the variable [MCT1], a constant scaling factor LACTEx , and the concentration of lactate in the
rods [LACTr ] as

[LACTEx ] = LACTEx [MCT1][LACTr ].
It has been reported that an increased lactate abundance upregulates MCT1 expression52,53. As a first approximation we model the expression of MCT1 as a linear function of the abundance of lactate in the rods as

[MCT1] = cM1 [LACTr ]
where cM1 is a regulatory constant. In healthy conditions, MCT1 is abundant enough to allow a normal amount
of lactate to be cleared out from the photoreceptors and transported into the RPE. This case is represented by
the maximal value cM1 = 1. Any value of the parameter cM1 < 1 would mean that there is a shortage in MCT1
expression, decreasing the lactate that can be cleared out from the photoreceptors and transported into the RPE.
The RPE uses the lactate lactate generated by the outer retina to produce pyruvate by means of LDHB. Recall
that under healthy conditions the RPE acquires most of its lactate in this way, instead of by directly metabolizing
glucose through glycolysis. Note that the minimum value cM1 = 0 represents a lack of MCT1 expression and,
thus, a blockage of lactate clearance in the photoreceptors. Such blockage also prevents the lactate form being
transported into the RPE, leading to a pyruvate shortage in it. This shortage activates its glycolysis, as modeled in
(15). We use the variable νPYR rE to define the reaction by which the rod-supplied lactate is converted into pyruvate
once inside the RPE, and to distinguish it from the lactate produced by the RPE’s glycolysis, as

νPYR rE =

Vmax[PYRrE ] [LACTEx ]2
2
Km
[PYR

rE ]

+ [LACTEx ]2

,

(29)

so that the total growth of pyruvate concentration in the RPE, [PYRE ] in (4), is given by the sum of the one produced from rod-supplied lactate, and the one produced by the RPE’s glycolysis. We have now defined all the terms
that form the system (1)–(11), which outlines the dynamics underlying the network in Fig. 2, and the feedback
model in Fig. 1. In the next sections we will analyze the solutions of this dynamical system, which represent the
abundance of every considered metabolite in time, both in healthy conditions and for some pathological cases.
Our results will be validated by comparison with experimental data.

Healthy conditions. Table 1 contains the parameters that represent the healthy or nominal conditions of
the dynamical system described in the previous section. Figure 4 shows the results of numerically solving the set
of differential equations for the case when GLUT1 is abundant, i.e., [GLUT1] = 1, for 500 min. After a short transient, all the metabolite concentrations, defined by the trajectories of the solutions, reached a long term level (i.e.,
a steady state), which represents the healthy concentrations of each of the metabolites included in Fig. 2. Note
that in order to maintain the the mathematical equations as simple as possible, our model includes only the key
components and mechanisms to analyse the interplay between glucose and lactate consumption and transport
between the rods and the RPE, assuming that some reactions always occur and clumping together some steps.
For this reason, some of our chosen parameters may show discrepancies with respect to experimental measurements available in the literature, in which rates or concentrations were measured for specific isolated reactions
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Parameter

Value

Source

Parameter

Value

Source

G

5 mM

+54

E

0.8 mM−1

◦

Vmax[gE ]

1.2 mM min−1

+55

LACTE

480 mM−1

◦

Km[gE ]

9 mM

55

r

21.7E−3 mM−1

◦

Vmax[G6PE ]

0.00738 mM min−1

–

ψ[PYRE ]

710 min−1

◦
+

Km[G6PE ]

0.002844 mM

–

ψ[NADPHr ]

15E2 min−1

Vmax[gr ]

0.8 mM min−1

55

ψ[LACTr ]

96E2 min−1

◦

Km[gr ]

8 mM

55

ψ[G3Pr ]

0.02 min−1

+

Vmax[F16BPE ]

1.2285 mM min−1

⋄ +56

[GLUT1]

1

◦

Km[F16BPE ]

0.1106 mM

–

cM1

1

◦

Vmax[PYRE ]

0.00783 mM min−1

–

δr

13E8

◦

Km[PYRE ]

0.17 mM

–

[PYRE*]

4.6E−5 mM

◦

Vmax[PYRr E]

14 mM min−1

–

[PEP*]

1.65E−13 mM

◦

Km[PYRr E]

0.125 mM

*

qr

0.18

+

Vmax[F16BPr ]

1.365 mM min−1

+56

ρr

1E−3

+54

Km[F16BPr ]

3.5 mM

+56

[g r ] 0

0.1 mM

–

Vmax[G6Pr ]

0.1845 mM min−1

+57

[G6P r ] 0

0.45 mM

+

Km[G6Pr ]

0.09 mM

+54

[F16BP r ] 0

0.06 mM

+

Vmax[NADPHr ]

0.228 mM min−1

+58

[NADPH r ] 0

0.1E−8 mM

–

Km[NADPHr ]

0.45 mM

+58

[PYR r ] 0

0 mM

42

Vmax[PYRr ]

0.3915 mM min−1

+57

[LACTr ] 0

1E−4 mM

+

Km[PYRr ]

0.06 mM

57

[G3P r ] 0

2.5E−6 mM

+

Vmax[G3Pr ]

0.15 mM min−1

+54

[gE] 0

3 mM

+

Km[G3Pr ]

0.143 mM

+54

[G6PE] 0

5E−3 mM

–

Vmax[LACTr ]

0.14 mM min−1

+

[F16BPE] 0

0.13 mM

–

Km[ LACTr ]

1.25E−5 mM

–

[PYRE] 0

0 mM

42

Table 1.  Parameters and initial conditions for the numerical simulations under healthy conditions. The
parameters marked as (+), are used exactly as they appear in Camacho et al.50, and the reference where they
were originally reported is provided when applicable. The parameter marked as (⋄) is within ± 10% of the
value reported in the provided reference. The parameters marked as (◦) are scaling constants added to this
model and do not represent any real kinetic or concentration value in the cells. The parameters marked as (−)
are estimated for this example by performing a systematic parameter sweep in which their values were changed
by a small fraction. This sweep was iterated many times until the responses provided the best qualitative
approximation to the available experimental data, as mentioned in “Model validation” section. The value of
parameter Km[PYRrE ] (marked with *) is equal to the value of parameter Km[LACT] in50 because the enzyme Lactate
dehydrogenase b (LDHB) enables the transformation of pyruvate into lactate, and vice versa.

or metabolites. Therefore, these parameters should not be interpreted as an exact quantitative values of what
would be observed in the lab, but as a qualitative reference of the cells’ mechanisms and of how the functionality
may change when perturbed. See SI 4 for a discussion on the model’s sensitivity to variations on the parameters.
Model validation. To test the validity of the result given by our mathematical model, we compared the numerically obtained long term, i.e., steady state, concentration with experimental data. We used the experimental data
in Kanow et al.42 to see how well it matched our model results. In this work, the incorporation of glucose to the
retina and to the RPE were compared, and several metabolite concentrations in both cells were analyzed. In particular, they considered the lactate and pyruvate concentrations in both types of cells, at six different moments in
time. First, we plotted the experimental data, performing a unit conversion assuming a protein concentration of
20 mg/ml (see SI 1 for details) as reported in Du et al.59 (the orange markers on Fig. 5 represent the mean values
(n = 3 for each time point), and the vertical lines the standard error). For the first 15 min, approximately, the
experimental metabolite concentrations show great variation, which is reduced after minute 30 for the lactate
in the rods and the pyruvate in the RPE. We then plotted the numerical time series of lactate and pyruvate in
the rods, and pyruvate in the RPE, using the basal values, i.e., initial conditions, and parameter values in Table 1
(continuous blue lines on Fig. 5). The transitory time and the qualitative approach to the equilibrium of our
numerical simulations correspond to those of the available experimental data. After 60 min it can be expected
that metabolite concentrations reach a relatively stable equilibrium, although this can be difficult to measure
with great precision in the lab due to noise and instrument errors. For this reason, we focus on obtaining the
closest qualitatively approximation to the experimental data rather than on accurately fitting every data point
with our numerical simulations. By doing so, we obtain a baseline that represents a healthy case with which to
compare the deviations that perturbations would induce.
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Figure 4.  Metabolites’ steady state solutions. Here we show the time series resulting from numerically solving
the system of differential Eqs. (1)–(11) for 500 min under healthy conditions, i.e., using the parameters and
initial conditions of Table 1. Individual panels correspond to every node (metabolite) depicted in the network
of Fig. 2, which is modeled by the differential Eqs. (1)–(11). Blue lines represent the concentration of the
corresponding metabolite in time. After a short transient, or settling time, every metabolite reaches a feasible
steady state. We refer to this steady state concentration as the healthy concentration or the healthy case, as it
represents a qualitative baseline for analysing how the system responds to perturbations.

Figure 5.  The concentrations obtained from running numerical simulations of system (1)–(11) for 120 min,
compared to the mean of the experimental results in Kanow et al.42. Using a protein concentration of 20 mg/ml
as reported in Du et al.59, we converted the mean of the experimental data (n = 3 for each time point)42 given in
pM/µg, to mM/ml (orange markers) and compared our numerical results (blue lines) to the experimental data
for lactate (top) and pyruvate (center) in the rods, and pyruvate in the RPE (bottom). In this figure the vertical
orange lines represent the standard error.

Scientific Reports |
Vol:.(1234567890)

(2022) 12:10645 |

https://doi.org/10.1038/s41598-022-13950-3

12

www.nature.com/scientificreports/
[GLUT1] modulation. The main motivation of this work is to analyse the effects of varying the concen-

tration of GLUT1 in the rods and the RPE, and to investigate the role played by the regulating mechanisms in
promoting glucose and lactate uptake and transport between the RPE and rods. It is widely known that glucose
is the main energy source of the retina and that the photoreceptors metabolize it mainly through aerobic glycolysis, releasing lactate as a product. Also, it is known that the RPE’s main metabolic process is OXPHO, which
needs pyruvate as a substrate, and that most of this pyruvate requirement does not come from its own glycolysis,
but from the conversion of the lactate transported from the photoreceptors and other retina cells29,46. Therefore,
the adequate regulation of the glucose and lactate flow within the retina is fundamental for maintaining sight.
It has been experimentally demonstrated that GLUT1 is the main glucose transporter36, that it is found on
both surfaces of the RPE60, and that the rods suffer from glucose deprivation induced by a decrease of GLUT1
expression28 ; however, the exact mechanisms that allow the RPE to maintain its basic functions when glucose
is scarce, and the effects of varying GLUT1 beyond the experimentally tested concentrations are unknown. In
this section we run numerical simulations of the mathematical model presented in “Mathematical model” section with different values of the parameter [GLUT1]. These values ranged from 1 (healthy concentration) to
0 (complete exhaustion), and we analyzed the steady state induced at every step. While knockout techniques
allow one to experimentally test for a few different concentrations of GLUT1 (see Swarup et al.28 and discussion
below), this numerical approach supports the examination of varying degrees of failure of the system with any
desired resolution between them. This technique has been used to trace the progression of retinitis pigmentosa
in Camacho et al.9 and to quantify the metabolic death kinetics of photoreceptors10.
To test the validity of our model in predicting the effect of different levels of [GLUT1], we compared the
results of our simulations with the experimental data reported in Swarup et al.28, obtained from using conditional knockout mice to study the impact on photoreceptors of reducing glucose transport across the RPE. In
Swarup et al.28, the glucose and lactate intensities are measured in six specimens of control mice retinas, as well
as in four specimens of medium GLUT1 knockout mice retinas (RPEGLUT1m ), which have approximately
50% RPEGLUT1 recombination, i.e., express approximately 50% of the control amount of GLUT1. The study
also considers six specimens of high GLUT1 knockout mice retinas (RPEGLUT1h), which have > 70% RPE
GLUT1 recombination, i.e., express < 30% of the control amount of GLUT1. Since the available experimental
data, obtained by mass spectrometry analysis of the specimens, was expressed in terms of metabolite intensities,
and quantified with internal standards, we used relative concentrations in order to adequately compare it to our
numerical data. To this end, we calculated the median of the glucose and lactate intensities found among the
control specimens and we scaled every intensity measurement of each specimen with respect to that value (see
SI 2 for details). The relative metabolites’ intensities are illustrated by the purple circles (control mice), squares
(RPEGLUT1m mice), and triangles (RPEGLUT1h mice) in both panels of Fig. 6. The median of every group
is shown by the orange horizontal lines. Note that the median of the control group, in both panels, has a value
of 100, since the scaling was performed with respect to them. Next, we iteratively ran our model fixing all the
parameters to the values in Table 1, except for [GLUT1] which was varied by a small amount for every run. We
recorded every resulting steady state concentrations of [gr ] and [LACTr ], normalized to the case of [GLUT1] = 1
(see SI 2). Then, we looked for the set of numerical concentrations of both metabolites that most closely matched
the medians of the experimental data (blue bars in Fig. 6). The [GLUT1] value that produced numerical results
closest to the RPEGLUT1m mice median is 0.44, which matches the approximately 50% RPEGLUT1 recombination. Furthermore, [GLUT1] = 0.18 produced numerical concentrations of [g r ] and [LACTr ] that were
closest to the median of the RPEGLUT1h mice which, correspondingly, express < 30% of the control amount
of GLUT1. Note that the bars representing both cases of [GLUT1] = 1 in Fig. 6 indicate a value of 100 because
the scaling was made with respect to them. This close match between the experimental data and the numerical
concentrations prove that our model can accurately track changes in GLUT1.
Analyzing the impact of [GLUT1] modulation. To test the impact of modulating GLUT1, we ran new simulations decreasing the parameter [GLUT1] value from 1 to 0, in 100 equal steps, and analyzed the resulting
metabolite levels represented by the trajectory of the solution curves. We initialized the simulations with the
nominal value [GLUT1] = 1, let them run for 1500 min to ensure that a steady state had been reached, and
recorded the resulting metabolite concentrations. These corresponded to the healthy state described in “Model
validation” section. Then, we decreased the value of [GLUT1] by 0.01, let the simulations run for another 1500
min and recorded again the steady state. We repeated this procedure decreasing the [GLUT1] value at each step
down to zero. To ensure that the changes in steady state concentration that we were recording were exclusively
due to the [GLUT1] variation, we performed an initial conditions dependency test; we found that the resulting
steady state concentration in every step of our experiment only depends only on the [GLUT1] concentration,
and not on the initial metabolite concentration (see SI 3 for details). In order to analyze the change in concentration of all metabolites simultaneously, we normalized every metabolite’s concentrations, as the value of [GLUT1]
varied, with respect to the steady state induced by [GLUT1] = 1. In other words, we made the nominal steady
state values be 100 and scaled the rest accordingly (see SI 2 for details).
The triangles in Fig. 7 represent the recorded relative steady state of every considered metabolite in our mathematical model, for each of the tested [GLUT1] values. The discontinuous black line in both panels illustrates
the constant progression of [GLUT1] deprivation, from abundance ([GLUT1] = 1), to complete exhaustion
([GLUT1] = 0). The right panel of Fig. 7 shows that all the metabolite concentrations in the rods decrease as
the [GLUT1] decreases, at different rates. This behavior is expected because as [GLUT1] decreases, less glucose,
which is the source of all the other rods’ metabolites, can enter the system. This observation coincides with the
progression of the [gr ] concentration, whose decrease is closest to the diagonal line. Note that this decrease is
relatively slower (less steep slope) up until the value of [GLUT1] has dropped significantly (at [GLUT1] ≈ 0.3).
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Figure 6.  The relative metabolite concentrations obtained from running numerical simulations of system (1)–
(11) match the experimental results of28. We iteratively ran our model with the parameters in Table 1 except for
[GLUT1], which was changed by a small fraction every time. For each simulation we let our system run until all
the metabolites had reached a steady state, and recorded the concentration values of glucose ([gr ]) and lactate
([LACTr ]) in the rods. We then calculated the relative concentrations of both metabolites with respect to the
case when [GLUT1] = 1, i.e., we gave the control case a value of 100 and scaled the rest accordingly. Then, we
looked for the [GLUT1] values for which the steady state most closely matched the data obtained in Swarup
et al.28 for the metabolite intensity of RPEGLUT1m, and RPEGLUT1h mice (expressing approximately 50%
and less than 30% of the control GLUT1 concentration, respectively). The purple circles, squares and triangles
mark the relative intensities of lactate and glucose in the the control, RPEGLUT1m, and RPEGLUT1h mice,
respectively, and the orange lines are the medians. Blue bars mark the numerical relative concentrations of [gr ]
and [LACTr ] when [GLUT1] = 1 (left), [GLUT1] = 0.44 (center) and [GLUT1] = 0.18 (right), which are the
closest match to the medians of the experimental data, and match the approximate GLUT1 expression in the
mice. We found that the scaling of our numerical results match the corresponding scaled experimental results.

This phenomenon can be attributed to the regulating functions that allow less glucose to be directed towards
the photoreceptors when the RPE experiences a shortage in its necessary nutrients. Note that towards the end
of the experiment (when [GLUT1]< 0.2) the [gr ] concentration decays towards zero very quickly. This behavior
is replicated by almost all the other metabolites in the rods, and will be interpreted later. The metabolite whose
concentration is most rapidly affected is [NADPHr ]. This is shown by the slope of the red line in the right panel
of Fig. 7 which is the steepest, indicating a faster rate of decrease. Reexamining the network of Fig. 2, note that
the link [G6Pr ]→[NADPHr ] is regulated by the function r which, as defined in (10), regulates the metabolite
flow between the rods’ glycolysis and PPP. The rapid decay of [NADPH r ] indicates that when a shortage of
nutrients appears, the pathway that is more quickly disfavored is the PPP, thus favoring the continuation of
glycolysis. In contrast, [LACTr ], [G6Pr ], [G3Pr ], and [F16BPr ] decay relatively slow in the rods as [GLUT1]
decreases, as illustrated by the brown, orange, pink and green lines respectively, in the right panel of Fig. 7 that
have less steep slopes for most of the experiment. These are glycolytic intermediates, obtained before and after
the diversion of flow to the KP, as illustrated in Fig. 2. Recall that the production of G3P is essential for the rods’
OS renewal process and thus, is fundamental for their survival, as expressed in (20). This suggests that the KP
was among the most favored pathways in the rods. By favoring the KP, the rods try to ensure their survival at
the cost of disfavoring other metabolic pathways such as PPP and OXPHO. Although OXPHO is not explicitly
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Figure 7.  Relative steady state concentrations of all metabolites in the RPE and the rods as [GLUT1] decreases
from 1 to 0, with all metabolites scaled to 100 at GLUT1 = 1 (representing the healthy case). Left panel:
Metabolite concentrations in the RPE. The glucose concentration in the RPE (gray curve) stays close to its
healthy value up until [GLUT1] has decreased by approximately 80% , i.e., [GLUT] = 0.2, likely due to the
regulating mechanisms that block the glucose passage to the rods. There is a slight increase in the G6P and
significant increase in the F16BP. Initially, the pyruvate concentration decreases at an almost constant rate
because it highly depends on the rods’ contribution of lactate, which is lower with every step. However, when
[GLUT1] decreases from approximately 0.45 down to 0.2, the rate at which pyruvate decreases and the rate at
which F16BP increases both slow down. As [GLUT1] becomes even scarcer ([GLUT1] less than approximately
0.2), the glucose concentration decays rapidly. Right panel: Metabolite concentrations in the rods. The RPE’s
regulating mechanisms block the passage of glucose to the rods, making its concentration decrease with every
step. As [GLUT1] decreases, the production of aerobic glycolysis intermediate products is favored (slowest
overall decrease). Among these are the production of G3P by the KP (essential for the rods’ OS renewal) and
the production of lactate (that contributes to the RPE’s survival); the others are G6P and F16BP. Meanwhile, the
production of NADPH (by the PPP, and the metabolite that undergoes the most rapid decrease) and pyruvate
(that fuels the rods’ OXPHO) are the most affected by the response of the regulating mechanisms to the
[GLUT1] decrease and the consequential glucose shortage. When [GLUT1] is less than approximately 0.2, the
glucose directed to the rods is too small to maintain any of its functions, and all the metabolites concentrations
rapidly go to zero.
included in our model, its obstruction is manifested by the rapid decay of [PYR r ] (purple line), which is its fuel
substance. This is supported by the fact that pyruvate is the substrate for lactate production by aerobic glycolysis
in the rods, so the quick reduction of [PYRr ] concentration and the contrasting slow decay of [LACTr ] (brown
line) means that most of the obtained pyruvate is destined to feed aerobic glycolysis, thus still contributing to
the RPE’s requirement of energy, at the cost of deterring its own OXPHO.
When [GLUT1]< 0.2, most of the metabolites’ concentrations decrease very quickly, except for [NADPHr ]
and [PYRr ] which are already very close to zero. In fact, at [GLUT1] = 0.2 the concentration of [G3Pr ], [LACT
r ], [G6P r ] and [F16BP r ] are around 50% of their nominal values. In contrast, the GLUT1 concentration is
only 20% of what is considered healthy. Recall that when [GLUT1] ≥ 0.3 the [gr ] slope is less steep than when
[GLUT1] becomes smaller; we can interpret this behavior as the rods’ attempt for survival by trying to draw more
glucose into the cell. This explains why the end products of KP and aerobic glycolysis can be still obtained at
relatively high rates. However, as the GLUT1 deprivation continues, this effort ends up succumbing, drawing the
concentration of all the metabolites to zero very rapidly, which leads to the cell’s inevitable death. This is known
in the context of ecosystems as a critical transition, that is, a transition to a state from which the organism cannot recover anymore. In short, we can conclude from our observations that when GLUT1 becomes scarcer, the
regulating mechanisms in the rods try to preserve certain functions at the expense of others. The function that is
mostly protected is their OS renewal, powered by the KP, and the production of lactate by aerobic glycolysis which
is then transported into the RPE. This can be interpreted as the rods choosing to mainly protect their own basic
survival and to maintain their contribution to the RPE’s energetic process, at the cost of rapidly shutting down
their own PPP and, at a slightly smaller pace, their OXPHO. This resistance of the rods against a perturbation
such as GLUT1 deprivation can only be sustained up to a certain point (approximately when [GLUT1] = 0.2)
after which all the rods functions are lost and the cell dies.
The left panel of Fig. 7 shows the RPE’s metabolite relative concentration variation as [GLUT1] changes, which
displays some interesting behavior. GLUT1 is the facilitator of glucose absorption in the RPE but, even when
its concentration is decreasing at a constant rate, the concentration of [gE ] stays very close to its nominal value
for most of the experiment (gray line), only decreasing very quickly for [GLUT1]≤0.2 (identified as a critical
value in the above paragraph). Under normal conditions, the RPE directs most of the glucose absorbed from the
choroid to the photoreceptors, and this passage is regulated by function E (see the link [gE]→[G6PE ] in Fig. 2)
which, as defined in (21), redirects this flow in the event that the RPE’s pyruvate requirements are not met (see
Fig. 3). This requirement is mostly met by the photoreceptors’ contribution of lactate, transported into the RPE by
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MCT1, and converted to pyruvate by LDHB. We already discussed the decrease in the rods’ lactate concentration
as soon as the GLUT1 deficiency appears, which decreases their contribution to the RPE’s pyruvate provoking
a shortage. This induces the blocking of glucose redirection to the rods, favoring its retention in the RPE. Since
more glucose is allowed to stay in the RPE, even when the transporter’s concentration decreases, the RPE is
capable of maintaining a glucose concentration close to its healthy value. The next step in the RPE’s metabolic
process is regulated by E (the complementary function of E ) which, by its definition in (15), activates the
RPE’s glycolysis above its usual pace when pyruvate in the RPE is insufficient. This is the second consequence
of the cutback in the rods’ lactate contribution and leads to the rapid consumption of glucose to produce G6P,
reflected in the permanence of [G6PE ] close to its nominal value (olive line). G6P is converted into F16BP in
the next step, which is also accelerated by the glycolysis activation of function E . In fact, we can notice a large
accumulation of [F16BPE ] in the RPE as [GLUT1] gets smaller (cyan line). We attribute this accumulation to the
cell’s response to the lack of outside nutrients, which is more severe with every decrease in [GLUT1].
Now we look at the last step in the RPE’s metabolic pathway in our model, which involves the production
of pyruvate from F16BP, and from the lactate received from the interphotoreceptor matrix. The sum of the
concentrations resulting from these two reactions is represented by [PYRE ] (magenta line), which displays an
almost constant rate of decrease as [GLUT1] declines, up until when [GLUT1] is approximately 0.45. After this
point the slope of [PYRE ] flattens, maintaining a concentration that changes very little until the very last part
of the experiment. This apparent stabilization of the [PYRE ] concentration can also be observed in the rise of
the concentration of [F16BPE ], which we attributed above to the cell’s response to starvation. Interestingly, the
same stabilization can be observed in the concentration of [G6PE ], as mentioned before. This phenomenon
suggests that when the outside lactate begins to be scarce, the RPE prepares itself for survival without this
contribution, switching to another state where it is capable of maintaining its functions autonomously. Remarkably, this mechanism seems to start very early in the progression of [GLUT1] deprivation. This explains how,
although being highly dependent on the rods’ lactate under normal conditions, the RPE’s pyruvate can maintain
a constant concentration while [GLUT1] concentration is below the identified critical level. However, this can
only be maintained while enough glucose can enter the RPE to feed its glycolysis, which fails to happen by the
end of the experiment. At this point [GLUT1] becomes so small that even with the passage of glucose to the
rods completely blocked, as evidenced by the quick decrease of [g r ] analyzed before, the glucose kept in the
RPE is insufficient to maintain its glycolysis. Then, the concentration of the RPE’s metabolites is drawn to zero
very quickly, which we interpret as the death of the cell. In summary, in the case of a nutrient deprivation, the
RPE’s activates mechanisms to preserve its functionality by decreasing the passage of glucose to the rods for its
own use. The same mechanisms activate its glycolysis, progressively switching to a state where it can function
independently from the rods. Nevertheless, as [GLUT1] becomes insufficient to bring in the minimal glucose
required by the RPE, the cell will experience a critical transition to a state where all the metabolites concentrations go to zero, which leads to its death.

Conclusions

We have presented here a model that synthesizes key metabolic functions in the rods and the RPE, the mechanisms that regulate them, and the metabolite feedback between the two types of cells. We illustrated the proposed
model in the form of a block diagram and of a network, specifying the considered pathways, metabolites and
regulating mechanisms. Based on the only existing mathematical model of the cones50, we built a mathematical
representation of our model that enables the computational analysis of the concentration of key metabolites in
the RPE-rods unit, under different conditions. We also selected a set of parameters that define the healthy state
of both cells, according to various sources in the literature, and estimated those that weren’t already available. We
then ran computational simulations of this healthy case to determine the abundance of our model’s metabolites,
and compared the numerical results to the available experimental data. The close match between our numerical
results and the experimental measurements validated our model (see Fig. 5).
The main motivation for building this model was to be able to analyse the effects in the concentration of all
the considered metabolites when [GLUT1] was modulated for a greater number of values than in the previously
analyzed experimental cases (GLUT1 at 100%, 50%, and less than 30% of the healthy concentration). Glucose
deficiency has been suggested to cause cone photoreceptor cell death in patients with rod dystrophies. Our objective was to gain insight on how the cells’ regulating mechanisms maintain homeostasis in healthy and compromised conditions. To this end, we defined the parameter [GLUT1] which represents the proportion of GLUT1
availability, relative to the healthy case (represented by [GLUT1] = 1). We ran simulations with [GLUT1] = (1,
0.44, and 0.18) and compared the numerical steady state results to the available experimental data. The response
of our model to a variation of [GLUT1] was validated by the close match between the numerical results and the
experimental measurements (see Fig. 6).
Then, we simulated our model with [GLUT1] = 1 and gradually decreased the parameter’s value to zero in
100 equal steps (0.01 decrease in each step), allowing the system to reach a steady state. By the analysis of all
the different steady state concentrations obtained, we found that the regulating mechanisms in the rods act to
preserve some of the cell’s functions, while some others are neglected. As [GLUT1] decreases the metabolites
concentrations that are largest are considered to be most favored. In particular, we noticed that the production
of G3P in the KP , and the the production of LACT, G6P and F16BP, which are created during aerobic glycolysis
(see right panel of Fig. 7) are favored. This suggested that the rods prioritize their own survival by ensuring their
OS renewal (mostly enabled by G3P) and they also try to maintain aerobic glycolysis sacrificing the NADPH
production in the PPP. Interestingly, pyruvate (the fuel for the rods’ OXPHO) also decays very quickly. However,
when [GLUT1] is near complete exhaustion and not enough glucose can enter the rods to maintain aerobic
glycolysis and the G3P production, all the metabolite concentrations collapse to zero, which represents a critical
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transition to the ceasing of all the cells’ functions and its consequential death. Meanwhile, as the value of [GLUT1]
decreased, we observed a great increase in one of the intermediate products of the RPE’s glycolysis, F16BP, and
a permanence close to its nominal value in the other, G6P (see left panel of Fig. 7). This, along with the slow
but steady decline of the RPE’s pyruvate concentration for values of [GLUT1] less than 0.5, corresponding to
the rods’ lactate level of approximately 0, led us to conclude that this cell, which in healthy conditions is highly
dependent on the rods, is capable of surviving independently of rods’ lactate contribution by changing the way
it functions, as long as it can uptake enough glucose. When the RPE’s glucose intake is insufficient to maintain
this alternative mode of functioning, which happens when [GLUT1] is extremely low, all the RPE’s metabolite
concentrations collapse to zero. This critical transition represents the death of the cell.
The mathematical model presented here offers many possibilities to explore the effects of changes in any of
its parameters, each of which represents a physiological characteristic of the RPE-rod unit, enabling the analysis
of its behavior under many different conditions beyond the ones explored here. For example, the mechanisms’
response to perturbations, and their relative contribution to promote survival can be tested. An interesting perturbation that can easily be implemented by changing only one parameter is a hyper or hypoglycemic state. In
Harder et al.61 the impact of disturbing glucose and pyruvate levels on metabolism when intra-ocular pressure
is elevated is demonstrated. Moreover, oral pyruvatye administration is proposed as a treatment that protects
from neurodegeneration in models of glaucoma. Yet, the exact mechanism by which the treatment contributes
to protect sight is not completely known. Another direction of future work could be to introduce a variable representing oxygen availability, and exploring the behaviour of the system when its gradient is changed, comparing
it to existing data from experiments in mice62,63. The model presented here offers the opportunity to shed light
to these mechanisms at the cost of finding suitable sets of parameters. This cost is low when compared to the
resources that wet experiments covering a wide range of conditions would require. We envisage that the numerical data produced by conducting in silico experiments using this model will help experimentalists prioritize and
narrow down new experiments, leading to a more effective use of lab resources. Experimental discoveries, in
turn, would help tune and add to the functionalities of the model. This work is a first approximation to building a
mathematical and computational model of the lactate-mediated metabolic exchange in the retina. Future possible
work includes the addition of pathways that are not included here such as OXPHO, TCA cycle, photoreceptors’
lactate uptake, etc, or other types of cells (for example, the Muller cells). We expect that this model will grow in
components and functionality along with new experimental findings.

Methods

All the simulations, plots and statistical analysis wereperformed using Python. For the numerical integration
we used the Real-valued Variable-coefficient Ordinary Differential Equation solver odeint from scipy.
integrate. For all the plots we used matplotlib.
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